Modular Medical, Inc.
News
Modular Medical Announces Finalization of Protocol for GLP-1 Personalized Metabolic Therapy Study Utilizing the MODD1 Platform
Accesswire -Proof of Concept Study in Rapid Acting GLP-1 to commence in October 2024 with data expected in November 2024-Pre-clinical study to explore use of MODD1 pump as a personalized delivery system for...\n more…
Registration Is Now Open For Tribe Public's Webinar Event "Diabetes, Obesity, GLP-1, & The MODD-1 Opportunity" Featuring Modular Medical CEO On Wednesday, September 11, 2024
Accesswire Meet with Modular Medical CEO, Jeb BesserThere are more than 3 million individuals who use daily insulin to help with the care of Diabetes in the US.100% of patient population require daily insulin...\n more…
Why Modular Medical Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket
Benzinga Shares of Modular Medical, Inc. MODD rose sharply in today's pre-market trading. The company announced the FDA clearance of the MODD1 insulin pump. Modular Medical shares jumped 29.1% to $2.53 in the pre-market trading. Here are some other stocks moving in pre-market trading. Eastside Distilling, Inc.\n more…
Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump
Accesswire SAN DIEGO, CA / ACCESSWIRE / September 4, 2024 / Modular Medical, Inc. (the 'Company' or 'Modular Medical') (NASDAQ:MODD), an insulin delivery system technology company preparing to launch a market...\n more…
Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump
Accesswire MODD1 is a patch pump for ALL adults with Type 1 and Type 2 diabetesDesigned to be simpler and more affordable to expand access to diabetes technology for previously underserved communitiesCommercial...\n more…
Modular Medical Incentivizes FDA Milestones with Stock Options
TipRanks Financial Blog Modular Medical (MODD) has provided an announcement. Modular Medical, Inc. introduced a Bonus Program to motivate its employees with stock options as rewards for ac...\n more…